يعرض 1 - 10 نتائج من 361 نتيجة بحث عن '"Gisslinger H"', وقت الاستعلام: 1.39s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

    المؤلفون: Barosi, G, Tefferi, A, Besses, C, Birgegard, G, Cervantes, F, Finazzi, G, Gisslinger, H, Griesshammer, M, Harrison, C, Hehlmann, R, Hermouet, S, Kiladjian, JJ, Kroger, N, Mesa, R, Mc Mullin, MF, Pardanani, A, Passamonti, F, Samuelsson, J, Vannucchi, AM, Reiter, A, Silver, RT, Verstovsek, S, Tognoni, G, Barbui, T

    المصدر: Leukemia. 29(1):20-26

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:130480588Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project

    المؤلفون: Barosi, G, Mesa, R, Finazzi, G, Harrison, C, Kiladjian, JJ, Lengfelder, E, McMullin, MF, Passamonti, F, Vannucchi, AM, Besses, C, Gisslinger, H, Samuelsson, J, Verstovsek, S, Hoffman, R, Pardanani, A, Cervantes, F, Tefferi, A, Barbui, T

    المصدر: Blood. 121(23):4778-4781

    مصطلحات موضوعية: Medicin och hälsovetenskap

    الوصول الحر: http://kipublications.ki.se/Default.aspx?queryparsed=id:127146964Test

    View record in SwePub النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms

    المؤلفون: Pecquet, C, Papadopoulos, N, Balligand, T, Chachoua, I, Tisserand, A, Vertenoeil, G, Nédélec, A, Vertommen, D, Roy, A, Marty, C, Nivarthi, H, Defour, J-P, El-Khoury, M, Hug, E, Majoros, A, Xu, E, Zagrijtschuk, O, Fertig, TE, Marta, DS, Gisslinger, H, Gisslinger, B, Schalling, M, Casetti, I, Rumi, E, Pietra, D, Cavalloni, C, Arcaini, L, Cazzola, M, Komatsu, N, Kihara, Y, Sunami, Y, Edahiro, Y, Araki, M, Lesyk, R, Buxhofer-Ausch, V, Heibl, S, Pasquier, F, Havelange, V, Plo, I, Vainchenker, W, Kralovics, R, Constantinescu, SN

    العلاقة: https://ora.ox.ac.uk/objects/uuid:5996735f-454d-4fec-a05a-aa6e3aa252ccTest; https://doi.org/10.1182/blood.2022016846Test

    الإتاحة: https://doi.org/10.1182/blood.2022016846Test
    https://ora.ox.ac.uk/objects/uuid:5996735f-454d-4fec-a05a-aa6e3aa252ccTest

    View record in BASE

    أضف إلى المفضلة
  4. 4
    مؤتمر
    Thromboembolism and bleeding in newly diagnosed Multiple Myeloma – Rates, risk profile and patterns of thromboprophylaxis

    المؤلفون: Vospernik, L., Agis, H., Ay, C., Rüsing, L. Z., Gisslinger, H., Simonitsch-Klupp, I., Krauth, M. T., Riedl, J.

    المصدر: GTH Congress 2024 – 68th Annual Meeting of the Society of Thrombosis and Haemostasis Research – Building Bridges in Coagulation ; Hämostaseologie ; ISSN 2567-5761

    الإتاحة: https://doi.org/10.1055/s-0044-1779097Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

    المؤلفون: Tefferi, A, Al-Ali, H, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J-J, Mesa, R, Passamonti, F, McMullin, M, Ribrag, V, Schiller, G, Vannucchi, A, Zhou, D, Reiser, D, Zhong, J, Gale, R

    المصدر: Leukemia. 31(4)

    مصطلحات موضوعية: Adult, Aged, Aged, 80 and over, Biomarkers, Erythrocyte Transfusion, Female, Humans, Immunologic Factors, Male, Middle Aged, Myeloproliferative Disorders, Phenotype, Primary Myelofibrosis, Thalidomide, Treatment Outcome, Workflow

    وصف الملف: application/pdf

    الوصول الحر: https://escholarship.org/uc/item/68k2q7szTest

    View record in eScholarship

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    S196: ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES

    المؤلفون: Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Empson, V., Krejcy, K., Hasselbalch, H., Kralovics, R., Kiladjian, J.-J.

    المصدر: HemaSphere ; volume 6, page 97-98 ; ISSN 2572-9241

    الإتاحة: https://doi.org/10.1097/01.hs9.0000843676.80508.b5Test

    View record in BASE

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

    المؤلفون: Cervantes F., Ross D. M., Radinoff A., Palandri F., Myasnikov A., Vannucchi A. M., Zachee P., Gisslinger H., Komatsu N., Foltz L., Mannelli F., Passamonti F., Gilotti G., Sadek I., Tiwari R., Zor E., Al-Ali H. K.

    المساهمون: Cervantes, F., Ross, D. M., Radinoff, A., Palandri, F., Myasnikov, A., Vannucchi, A. M., Zachee, P., Gisslinger, H., Komatsu, N., Foltz, L., Mannelli, F., Passamonti, F., Gilotti, G., Sadek, I., Tiwari, R., Zor, E., Al-Ali, H. K.

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34017073; info:eu-repo/semantics/altIdentifier/wos/WOS:000652451300002; volume:35; issue:12; firstpage:3455; lastpage:3465; numberofpages:11; journal:LEUKEMIA; https://hdl.handle.net/11383/2143464Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85106298764

    الإتاحة: https://doi.org/10.1038/s41375-021-01261-xTest
    https://hdl.handle.net/11383/2143464Test

    View record in BASE

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    The impact of thrombosis on probabilities of death and disease progression in polycythemia vera: a multistate transition analysis of 1,545 patients

    المؤلفون: Barbui T., Carobbio A., Thiele J., Gangat N., Rumi E., Rambaldi A., Vannucchi A. M., Tefferi A., Jeryczynski G., Mullauer L., Vaidya R., Sulai N. H., Pardanani A., Larson D. R., Cazzola M., Casetti I., Finazzi G., Pieri L., Gisslinger H., Gisslinger B., Rodeghiero F., Ruggeri M., Randi M. L., Bertozzi I., Passamonti F.

    المساهمون: Barbui, T., Carobbio, A., Thiele, J., Gangat, N., Rumi, E., Rambaldi, A., Vannucchi, A. M., Tefferi, A., Jeryczynski, G., Mullauer, L., Vaidya, R., Sulai, N. H., Pardanani, A., Larson, D. R., Cazzola, M., Casetti, I., Finazzi, G., Pieri, L., Gisslinger, H., Gisslinger, B., Rodeghiero, F., Ruggeri, M., Randi, M. L., Bertozzi, I., Passamonti, F.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/38102114; info:eu-repo/semantics/altIdentifier/wos/WOS:001125467800001; volume:13; issue:1; firstpage:187; journal:BLOOD CANCER JOURNAL; https://hdl.handle.net/11577/3508655Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85179700627

    الإتاحة: https://doi.org/10.1038/s41408-023-00960-1Test
    https://hdl.handle.net/11577/3508655Test

    View record in BASE

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

    المؤلفون: Vannucchi, AM, te Boekhorst, Peter, Harrison, CN, He, GS, Caramella, M, Niederwieser, D, Boyer-Perrard, F, Duan, MH, Francillard, N, Molloy, B, Wroclawska, M, Gisslinger, H

    المصدر: Vannucchi , AM , te Boekhorst , P , Harrison , CN , He , GS , Caramella , M , Niederwieser , D , Boyer-Perrard , F , Duan , MH , Francillard , N , Molloy , B , Wroclawska , M & Gisslinger , H 2019 , ' EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis ' , Haematologica , vol. 104 , no. 5 , pp. 947-954 . https://doi.org/10.3324/haematol.2018.204602Test

    مصطلحات موضوعية: /dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM024104, name=EMC MM-02-41-04

    وصف الملف: application/pdf

    العلاقة: https://pure.eur.nl/en/publications/b939f552-eafc-4232-b060-2d69f8feed8fTest

    الإتاحة: https://doi.org/10.3324/haematol.2018.204602Test
    https://pure.eur.nl/en/publications/b939f552-eafc-4232-b060-2d69f8feed8fTest
    https://pure.eur.nl/ws/files/48192730/Repub_116826_O-A.pdfTest
    http://hdl.handle.net/1765/116826Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Comments on pre-fibrotic myelofibrosis and how should it be managed

    المؤلفون: Barbui T., Thiele J., Gisslinger H., Orazi A., Vannucchi A. M., Gianelli U., Beham-Schmid C., Tefferi A.

    المساهمون: T. Barbui, J. Thiele, H. Gisslinger, A. Orazi, A.M. Vannucchi, U. Gianelli, C. Beham-Schmid, A. Tefferi

    مصطلحات موضوعية: bone marrow morphology, clinical data, essential thrombocythaemia, pre-fibrotic myelofibrosi, prognosis, Settore MED/08 - Anatomia Patologica, Settore MED/15 - Malattie del Sangue

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30847907; info:eu-repo/semantics/altIdentifier/wos/WOS:000474639800025; volume:186; issue:2; firstpage:358; lastpage:360; numberofpages:3; journal:BRITISH JOURNAL OF HAEMATOLOGY; http://hdl.handle.net/2434/677709Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85062787406

    الإتاحة: https://doi.org/10.1111/bjh.15840Test
    http://hdl.handle.net/2434/677709Test

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث